MAT Clinics in Indiana: Methadone, Suboxone & Vivitrol Treatment

Find treatment options, compare medications and explore 26 Medicare-enrolled methadone opioid treatment program (OTP) locations across 22 Indiana cities. This Indiana guide also explains Medicaid coverage, telehealth, overdose prevention and ways to seek help in counties without an OTP listing.

On this page — jump to a section
  1. Indiana MAT at a Glance
  2. Get Help Finding a Clinic
  3. Find MAT Clinics by City
  4. Treatment Options by Medication
  5. Methadone Clinic Rules
  6. Paying for MAT
  7. Telehealth MAT
  8. Opioid Overdose Trends
  9. Areas with Limited MAT Access
  10. Indiana Resources & Helplines
  11. Special Populations
  12. How to Choose a Clinic
  13. FAQs About MAT
  14. Sources and Editorial Standards
  15. Nearby States

Indiana MAT at a Glance

26Methadone OTP locationsCMS, Sep 8, 2026
22Cities with an OTPCMS, Sep 8, 2026
21 of 92Counties with an OTPCMS, Sep 8, 2026
71Counties without a listed OTPCMS, Sep 8, 2026
YesMedicaid expansionKFF; HIP since 2015
3 medicationsCovered under Medicaid MOUD benefitFederal Medicaid law
25.72024 drug overdose deaths per 100,000CDC NCHS / KFF

What this means for you: Methadone services are concentrated in a small number of Indiana counties, so location, transportation and office-based buprenorphine options can shape a practical care plan.

Get Help Finding a Clinic in Indiana

Need help exploring Indiana treatment options?

Speak with a treatment navigator about methadone clinics, Suboxone care, Medicaid and possible next steps. You can also send an inquiry through the form.

Call 1-(347) 591-7540
Your Information - Step 1 of 2

For an overdose or immediate danger, call 911. For crisis support, call or text 988. SAMHSA National Helpline: 1-800-662-4357.

MATClinicGuide is a treatment-navigation resource, not a clinic. Calls reach our navigation line and may be answered or routed to participating treatment providers or partners, not necessarily the clinics listed here.

Find MAT Clinics by City in Indiana

The September 8, 2026 CMS Medicare OTP enrollment list identifies 26 locations in 22 Indiana cities. These are Medicare-enrolled listings; they are not a complete count of all possible addiction care providers.

Top cities for methadone clinics

Indiana methadone OTP directory: 22 cities

Bloomington — 1 OTP

Limestone Health SAMHSA-certified OTP

2100 S Liberty Dr, Ste A, Bloomington, IN 47403-5147

(812) 727-6700 · Directions

Charlestown — 1 OTP

Southern Indiana Center SAMHSA-certified OTP

7509 Charlestown Pike, Charlestown, IN 47111-9623

(812) 256-4686 · Directions

Evansville — 1 OTP

Evansville Treatment SAMHSA-certified OTP

1510 W Franklin St, Evansville, IN 47710-1032

(812) 424-0223 · Directions

Fort Wayne — 2 OTPs

Center for Behavioral SAMHSA-certified OTP

3910 Lima Rd, Fort Wayne, IN 46805-1031

(260) 420-6010 · Directions

Bowen Health SAMHSA-certified OTP

1415 Directors Row, Fort Wayne, IN 46808-1297

(574) 385-3140 · Directions

Gary — 2 OTPs

Metro Treatment of Gary SAMHSA-certified OTP

5001 East Dunes Hwy, Gary, IN 46403-3114

(219) 938-4651 · Directions

Edgewater Systems for Balanced Living SAMHSA-certified OTP

1110 W 5Th Ave, Gary, IN 46402-1723

(219) 885-4264 · Directions

Greendale — 1 OTP

East Indiana SAMHSA-certified OTP

816 Rudolph Way, Greendale, IN 47025-8312

(812) 537-1668 · Directions

Greenwood — 1 OTP

New Vista Outpatient Recovery Center SAMHSA-certified OTP

65 Airport Parkway, Suite 104, Greenwood, IN 46143-1407

(317) 883-5330 · Directions

Indianapolis — 3 OTPs

Indianapolis Treatment SAMHSA-certified OTP

2626 E 46Th St, Ste J, Indianapolis, IN 46205-2373

(317) 475-9066 · Directions

New Vista North SAMHSA-certified OTP

4010 W 86Th St, Ste D, Indianapolis, IN 46268

(317) 887-1348 · Directions

Sandra Eskenazi Mental Health Center SAMHSA-certified OTP

3419 English Ave, Indianapolis, IN 46201-4328

(317) 880-8491 · Directions

Kokomo — 1 OTP

Kokomo Treatment Services (Pinnacle Treatment Centers) SAMHSA-certified OTP

2906 S Reed Rd, Kokomo, IN 46902-3991

(765) 558-2010 · Directions

La Porte — 1 OTP

Porter-Starke Services SAMHSA-certified OTP

1230 W State Road 2, Ste B, La Porte, IN 46350-5549

(219) 531-3500 · Directions

Lafayette — 1 OTP

Limestone Health SAMHSA-certified OTP

4705 Meijer Ct, Lafayette, IN 47905-4684

(765) 701-6060 · Directions

Marion — 1 OTP

Premier Care of Indiana SAMHSA-certified OTP

317 S Norton St, Marion, IN 46952-3296

(765) 664-0101 · Directions

Martinsville — 1 OTP

Pinnacle Treatment Centers – Martinsville SAMHSA-certified OTP

510 Grand Valley Blvd, Martinsville, IN 46151-5883

(765) 516-6292 · Directions

Merrillville — 1 OTP

Northwest Indiana Center SAMHSA-certified OTP

8500 Broadway, Ste H, Merrillville, IN 46410-7006

(219) 769-7710 · Directions

Muncie — 1 OTP

Muncie Comprehensive Treatment Center SAMHSA-certified OTP

3640 Briarwood Ln, Muncie, IN 47304-6375

(317) 475-9066 · Directions

Plainfield — 1 OTP

WIN Recovery – Hendricks (Hamilton Center) SAMHSA-certified OTP

401 Plainfield Commons Dr, Plainfield, IN 46168-2773

(317) 268-2941 · Directions

Richmond — 1 OTP

Richmond Treatment Center SAMHSA-certified OTP

4265 S A St, Richmond, IN 47374-6049

(765) 962-8843 · Directions

Seymour — 1 OTP

Seymour Treatment Center SAMHSA-certified OTP

357 Tanger Blvd, Ste 215, Seymour, IN 47274-3597

(812) 558-9016 · Directions

South Bend — 1 OTP

Victory Clinical SAMHSA-certified OTP

4218 W Western Ave, South Bend, IN 46619-2622

(574) 233-1524 · Directions

Terre Haute — 1 OTP

WIN Recovery – Vigo (Hamilton Center) SAMHSA-certified OTP

88 Wabash Ct, Terre Haute, IN 47807-3439

(812) 231-8438 · Directions

Valparaiso — 1 OTP

Porter-Starke Services SAMHSA-certified OTP

2507 Cumberland Dr, Valparaiso, IN 46383-2503

(219) 476-4676 · Directions

Vincennes — 1 OTP

WIN Recovery – Knox (Hamilton Center) SAMHSA-certified OTP

1433 Willow St, Vincennes, IN 47591-4207

(812) 494-2215 · Directions

Suboxone, buprenorphine and Vivitrol providers in Indiana

Suboxone doctors in Indiana and other buprenorphine providers may work in primary-care offices, psychiatry practices and addiction-medicine settings. To search beyond methadone clinics, use FindTreatment.gov or the Indiana DMHA provider finder. Ask about medication availability, insurance and whether the practice accepts new patients.

Listings use the CMS Medicare OTP provider file dated September 8, 2026. Contact clinics for current hours, admissions and insurance details.

MAT Treatment Options in Indiana by Medication

Methadone clinics in Indiana

Indiana has 26 CMS-listed methadone OTP locations across 22 cities. Indianapolis has three; Gary and Fort Wayne have two each. Methadone for opioid use disorder is dispensed through federally certified OTPs, where patients work with a clinical team to establish a schedule. Early treatment often requires frequent visits, making travel especially important in Indiana counties without an OTP.

For the treatment process, read our methadone treatment guide and OTP explanation.

Buprenorphine and Suboxone doctors in Indiana

Buprenorphine is an alternative to daily OTP-based methadone care for some people in Indiana. Qualified prescribers may offer it through medical offices, and telehealth Suboxone in Indiana can be an option when federal and state requirements are met. Unlike methadone for OUD, outpatient buprenorphine can be dispensed at a pharmacy with a valid prescription. A clinician determines whether it fits your health needs.

Learn how treatment works in the Suboxone and buprenorphine guide and explore MAT and MOUD terminology.

Long-acting buprenorphine: Sublocade and Brixadi

Long-acting injections, including Sublocade and Brixadi, may reduce the need to take a buprenorphine tablet or film every day. They are administered in an appropriate medical setting and do not replace the need for follow-up care. In Indiana, ask an addiction-medicine practice whether it administers these products, what starting requirements apply and whether your Medicaid or private plan covers the specific product.

See our Sublocade medication guide and treatment-duration guide.

Naltrexone and Vivitrol in Indiana

Extended-release naltrexone, known by the brand name Vivitrol, is a non-opioid medication option for some people with opioid use disorder. Unlike methadone and buprenorphine, it requires an opioid-free period before the first dose to avoid precipitated withdrawal. Indiana Medicaid’s medication treatment benefit includes naltrexone, though coverage details and administration requirements depend on the patient and plan. A clinician can review whether it is suitable.

Read more about naltrexone and Vivitrol treatment and medications for opioid use disorder.

MedicationWhere obtained in IndianaVisits at startIndiana Medicaid
MethadoneCertified OTPOften frequent OTP visitsCovered; confirm plan requirements
Buprenorphine / SuboxoneQualified prescriber and pharmacyClinician-dependentCovered; confirm plan requirements
Sublocade / BrixadiAppropriate medical practiceProduct- and care-plan-dependentAsk about product-specific coverage
Naltrexone / VivitrolPrescribing clinic / administering practiceInitial assessment; monthly injection for VivitrolCovered; confirm plan requirements

Methadone (OTP) Rules in Indiana

Indiana methadone OTPs are overseen by the Indiana FSSA Division of Mental Health and Addiction (DMHA) under state and federal requirements. DMHA describes OTP enrollment for adults age 18 or older with an opioid use disorder lasting at least one year. Clinics coordinate medication, medical monitoring and rehabilitative services.

Indiana OTP admissions and oversight

DMHA cites Indiana Code 12-23-18 and federal 42 CFR Part 8 among the rules governing opioid treatment programs. Indiana Code 12-23-18-5.5 currently limits approval of new OTPs, one reason existing regional sites matter. Speak with the program about eligibility, documentation and the first medical assessment before traveling.

Dosing, take-home medication and transfers

Federal OTP rules updated in 2024 allow clinicians more flexibility when assessing take-home methadone, but the Indiana program and clinical team determine the safe, applicable schedule. If you travel or move within Indiana, ask the current OTP about guest dosing or transfers and arrangements with the receiving program.

Preparing for your first appointment

Bring identification, current medication information, insurance or Indiana Medicaid details, and a way to contact your care team. Ask what medical evaluation, drug-screening procedures, counseling options and payment steps apply. For broader context, see how counseling relates to MAT: access to medication should not be described as contingent on completing counseling first.

Good to know: The DMHA opioid treatment program office is at 402 West Washington Street, Room W353, Indianapolis, IN 46204; main phone (317) 232-7800.

Paying for MAT in Indiana

Indiana Medicaid and the Healthy Indiana Plan

Indiana expanded Medicaid effective February 1, 2015. Adult expansion coverage operates through the Healthy Indiana Plan (HIP). The federal Medicaid medication treatment benefit includes methadone, buprenorphine and naltrexone for opioid use disorder, while Indiana-specific authorization, network and pharmacy rules may vary.

Check enrollment and benefits through Indiana Medicaid. If you are searching for MAT clinics that accept Medicaid in Indiana, confirm both the clinic and prescribing clinician participate in your plan.

Medicare

Medicare Part B includes a benefit for services at eligible opioid treatment programs. For medications outside an OTP, such as pharmacy-dispensed buprenorphine, Medicare Part D and individual plan terms may apply. Indiana’s CMS-listed OTP directory is a useful starting point, but enrollment in a federal dataset does not by itself confirm your personal coverage or a clinic’s intake status.

Private insurance

Commercial health plans may cover Indiana medication-assisted treatment, but networks, cost sharing, prior authorization and individual medications differ. Ask for the clinic’s billing team and your insurer’s substance-use treatment benefits before your first visit. Federal parity protections do not mean every service is automatically covered at every facility.

Uninsured and low-cost treatment

If you do not have health insurance, Indiana DMHA funds addiction services through community providers. Start with its Apply for Services page or call Indiana 211 to discuss options and possible transportation support. People looking for free methadone clinics in Indiana should ask directly whether grant-funded assistance or income-based fees are available; free admission should not be assumed.

ServiceMedicaid coverageNotes
Methadone for OUDYesCovered medication treatment benefit; OTP participation and billing requirements apply
Buprenorphine / SuboxoneYesCheck preferred products and plan requirements
Naltrexone / VivitrolYesCheck pharmacy/medical benefit and administration requirements

Compare payment routes in our insurance coverage guide, insurance verification page and MAT cost information.

Need help checking Indiana treatment options?

A navigator can help you identify questions to ask about costs, participating clinics and available treatment pathways.

Call 1-(347) 591-7540

For an overdose or immediate danger, call 911. For crisis support, call or text 988. SAMHSA National Helpline: 1-800-662-4357.

MATClinicGuide is a treatment-navigation resource, not a clinic. Calls reach our navigation line and may be answered or routed to participating treatment providers or partners, not necessarily the clinics listed here.

Telehealth MAT in Indiana

Indiana residents may be able to access buprenorphine care through telehealth under applicable federal and state rules. DEA/HHS telemedicine flexibilities for prescribing controlled medications currently extend through December 31, 2026; rules can change, and the clinician must still meet professional standards and applicable Indiana requirements.

Telehealth Suboxone in Indiana does not mean that a patient can obtain methadone for OUD from a retail pharmacy. Methadone for OUD remains an OTP-dispensed medication, though a program may use certain remote assessment tools when permitted. Ask a potential telehealth practice about its Indiana licensure, prescribing process, pharmacy options and follow-up care.

Policy checked: October 2026: Federal telemedicine flexibilities currently run through December 31, 2026. State rules and federal deadlines may change. Learn more in our telehealth MAT guide.

Opioid Overdose in Indiana: Why Access Matters

Indiana recorded 1,717 drug overdose deaths in 2024, according to CDC NCHS data presented by USAFacts. Its age-adjusted all-drug overdose death rate decreased from 43.0 per 100,000 in 2021 to 25.7 in 2024, but remained above the 2024 U.S. figure of 23.1.

Indiana’s opioid overdose death rate was 17.8 per 100,000 in 2024, versus 16.0 nationally. These figures describe population outcomes, not an individual person’s prognosis. Effective treatment and access to overdose-reversal medication remain important.

Indiana age-adjusted all-drug overdose death rates per 100,000 · CDC NCHS via KFF
2019
26.6
2020
36.7
2021
43.0
2022
41.0
2023
34.2
2024
25.7
YearIndiana: all drugsIndiana: opioids
201926.619.9
202036.729.9
202143.034.2
202241.032.0
202334.226.4
202425.717.8
Overdose prevention: Indiana’s 2026 statewide standing order supports access to naloxone and nalmefene through registered entities. Naloxone 4 mg nasal spray is available over the counter. See our naloxone and overdose response guide.

Areas of Indiana with Limited MAT Access

Seventy-one of Indiana’s 92 counties do not have a location in the September 2026 Medicare OTP directory. The suggested OTP cities below are starting points rather than travel-time estimates; use office-based buprenorphine searches, telehealth and Indiana 211 transportation assistance as needed.

Northeast Indiana

Counties and communities: Elkhart, Kosciusko (Warsaw), Noble, DeKalb, Steuben, LaGrange, Huntington, Wabash, Adams and Wells.

Nearest OTP cities to explore: Fort Wayne, South Bend, Marion.

North-central and rural northwest

Counties and communities: Marshall, Starke, Fulton, Pulaski, Cass (Logansport), Miami (Peru), White, Jasper and Newton.

Nearest OTP cities to explore: South Bend, La Porte, Valparaiso, Kokomo, Lafayette.

Indianapolis suburbs and east-central

Counties and communities: Hamilton (Carmel and Fishers), Madison (Anderson), Hancock, Shelby, Henry (New Castle), Randolph, Jay, Rush and Fayette.

Nearest OTP cities to explore: Indianapolis, Greenwood, Muncie, Richmond.

West-central Indiana

Counties and communities: Montgomery (Crawfordsville), Putnam, Parke, Clay, Owen, Greene and Sullivan.

Nearest OTP cities to explore: Terre Haute, Lafayette, Plainfield, Martinsville, Bloomington.

Southeast Indiana

Counties and communities: Bartholomew (Columbus), Jennings, Decatur, Ripley, Jefferson (Madison), Franklin and Switzerland.

Nearest OTP cities to explore: Seymour, Greendale, Charlestown.

Southern and southwest Indiana

Counties and communities: Floyd (New Albany), Harrison, Washington, Lawrence (Bedford), Orange, Dubois (Jasper), Daviess, Gibson, Warrick, Posey, Spencer and Perry.

Nearest OTP cities to explore: Charlestown, Evansville, Vincennes, Bloomington, Seymour.

Indiana 211 offers help locating treatment services and may arrange Lyft rides to substance-use treatment. People who live far from an OTP may also wish to compare office-based medications and telehealth options, where clinically appropriate.

Indiana Resources & Helplines

Indiana FSSA / DMHA

OTP oversight and addiction services. 402 West Washington Street, Room W353, Indianapolis, IN 46204. (317) 232-7800. Program information.

Indiana 211

Call 211 or 866-211-9966. Navigators: Monday–Friday, 7 a.m.–7 p.m. ET. Text your ZIP to 898-211, weekdays 8 a.m.–5 p.m. ET. Treatment rides may be available.

Overdose prevention

Indiana’s statewide 2026 naloxone/nalmefene standing order supports registered distribution and training. Naloxone 4 mg nasal spray is sold over the counter.

Crisis and emergency

Call or text 988 for crisis support; call 911 for an overdose or medical emergency. SAMHSA: 1-800-662-4357.

Naloxone access and Indiana Good Samaritan protection

Indiana’s overdose-response legal protection is limited. Under Indiana Code 16-42-27-2, certain simple possession protections apply to a person who administers naloxone, calls 911 around the time of the response, provides their name, remains at the scene and cooperates. The protection does not apply to the person who overdosed, and it is not blanket immunity for other charges.

For information about the 2026 statewide standing order and rescue medication, consult the Indiana Department of Health standing order. The OTP office can also be reached at OTP.FSSA@fssa.in.gov.

MAT for Special Populations in Indiana

Pregnant and postpartum people

People who are pregnant or postpartum in Indiana can discuss methadone or buprenorphine with an obstetric clinician and an addiction-treatment team. Sudden stopping of opioids without medical advice can carry risks. Ask an Indiana OTP or medical practice about coordinated prenatal services and postpartum follow-up. Treatment should be individualized rather than based on assumptions about pregnancy.

Veterans

Veterans in Indianapolis, Fort Wayne, South Bend and other Indiana communities can ask their VA care team about medication treatment for opioid use disorder and referrals when necessary. Not every VA location provides the same on-site services. A veteran can also consider Indiana community-based programs or a listed OTP after reviewing eligibility, travel and coverage with the care team.

Adolescents and young adults

Indiana DMHA describes its OTP enrollment criteria for adults 18 and older. For a younger person with opioid use disorder, begin with a pediatric or adolescent addiction specialist rather than assuming an adult methadone program can enroll them. Parents and caregivers can ask the DMHA provider finder or Indiana 211 for age-appropriate services. Early support and a confidential clinical conversation matter.

People leaving jail or prison

Continuity of medication treatment when leaving an Indiana jail or prison can reduce dangerous treatment interruptions. Before release, a person or discharge planner can identify an OTP, discuss a buprenorphine prescriber, transfer available records and arrange transportation to the first appointment. Any medication plan should follow the treating clinician’s guidance, and the receiving Indiana provider should confirm enrollment and access.

Rural residents

Residents of the 71 Indiana counties without a CMS-listed OTP may face longer trips for methadone services. Exploring office-based buprenorphine, state treatment referral services and permitted telehealth can widen the options. Indiana 211 also offers help with substance-use treatment transportation. Supportive family members can consult our guide to helping a loved one.

How to Choose a MAT Clinic in Indiana

Choosing among Indiana methadone clinics and buprenorphine practices starts with the medication you want to discuss, insurance arrangements, location and the clinic’s care approach. Use the questions below to compare services without assuming one medication is best for everyone.

Questions to ask methadone OTPs

  • Are you accepting new patients, and what are the intake steps?
  • What time must I arrive for dosing or an initial assessment?
  • What Indiana Medicaid plans or Medicare benefits can be billed?
  • What is your approach to take-home doses and travel-related guest dosing?
  • How are medical care, counseling and other support arranged?

Questions to ask buprenorphine prescribers

  • Do you offer buprenorphine, Suboxone or long-acting injections?
  • Can an Indiana resident be evaluated by telehealth when permitted?
  • Does your practice accept my plan or offer an income-based fee?
  • Which local pharmacy or office handles my prescribed medication?
  • What follow-up schedule and support services are available?

What happens at a first visit?

  1. Contact the Indiana OTP or prescriber and discuss basic eligibility.
  2. Share medical history, substance-use history and current medications with the clinical team.
  3. Complete any assessment the clinician determines is appropriate.
  4. Discuss medication options and agree on a follow-up plan.
Red flags: Be cautious of programs that promise guaranteed results, demand unexplained large advance payments or insist that counseling alone is the only legitimate path to medication treatment. Seek another clinical opinion when a plan does not address your questions.

Talk through your Indiana care options

Call our navigation line for questions to bring to a licensed provider or to discuss locating nearby services.

Call 1-(347) 591-7540

For an overdose or immediate danger, call 911. For crisis support, call or text 988. SAMHSA National Helpline: 1-800-662-4357.

MATClinicGuide is a treatment-navigation resource, not a clinic. Calls reach our navigation line and may be answered or routed to participating treatment providers or partners, not necessarily the clinics listed here.

FAQs About MAT Clinics in Indiana

How many methadone clinics are in Indiana?

The CMS Medicare OTP file dated September 8, 2026 lists 26 methadone OTP locations in 22 Indiana cities. Indianapolis has three, while Gary and Fort Wayne have two each. These counts describe Medicare-enrolled OTP locations, not all possible substance-use treatment facilities. Use the city directory on this page and contact a program about its current intake schedule.

Does Indiana Medicaid cover Suboxone?

Yes. Federal Medicaid law requires coverage of medications for opioid use disorder, including buprenorphine, the medication used in Suboxone. Indiana Medicaid and the Healthy Indiana Plan (HIP) may apply specific pharmacy, network or authorization requirements. Ask the prescribing practice and your Medicaid plan about the precise product and out-of-pocket costs.

Are there free methadone clinics in Indiana?

Indiana DMHA funds addiction services through community providers, but cost and eligibility depend on the program. The 26 CMS-listed Indiana OTP locations are not automatically free. If you are uninsured or cannot afford care, contact Indiana 211 or DMHA’s Apply for Services page and ask clinics about financial assistance or sliding-scale options.

Where can I find Suboxone doctors in Indiana?

Indiana residents can look for office-based buprenorphine prescribers through FindTreatment.gov and the Indiana DMHA Find a Local Service Provider tool. Start with your ZIP code and ask whether the office offers Suboxone or generic buprenorphine, accepts new patients and works with your insurance. There are also 26 Medicare-enrolled OTP locations listed separately for methadone care.

Can I get telehealth Suboxone in Indiana?

Telehealth buprenorphine may be available to Indiana patients when applicable federal and state prescribing requirements are met. Federal DEA/HHS controlled-medication telemedicine flexibilities currently extend through December 31, 2026. Telehealth does not guarantee a prescription or admission; a licensed clinician must evaluate the patient and explain pharmacy and follow-up requirements.

Are there methadone clinics near Carmel or Fishers, Indiana?

Hamilton County, including Carmel and Fishers, has no location in Indiana’s September 2026 CMS Medicare OTP listing. Indianapolis and Greenwood have listed OTPs worth exploring, although travel distance and admission availability should be checked directly. People in Hamilton County can also search for office-based buprenorphine treatment and consult Indiana 211 about transportation.

What are Indiana opioid treatment program rules?

Indiana FSSA’s Division of Mental Health and Addiction oversees state OTP requirements. DMHA describes enrollment for adults at least 18 years old with opioid use disorder for one year or more. Indiana Code 12-23-18-5.5 limits approval of new OTPs, and federal 42 CFR Part 8 also applies. Clinics establish clinical assessment and dosing arrangements under these rules.

Does Indiana Medicaid cover Vivitrol?

Yes. Naltrexone, including extended-release injection treatment such as Vivitrol, falls within the federally required Medicaid medication treatment benefit for opioid use disorder. The patient’s Indiana Medicaid coverage and provider arrangements can affect administration and authorization. A clinician must also assess the necessary opioid-free interval before starting naltrexone.

How can I find treatment in an Indiana county without an OTP?

Seventy-one of Indiana’s 92 counties have no location in the September 2026 CMS Medicare OTP listing. Options to explore include the closest regional OTP, office-based buprenorphine, permitted telehealth care and community treatment resources. Indiana 211 can help locate substance-use treatment and may coordinate a Lyft ride. Confirm available services before planning travel.

Where can I get naloxone in Indiana?

Indiana’s 2026 statewide standing order supports naloxone and nalmefene distribution through registered entities, and naloxone 4 mg nasal spray is available over the counter. Ask a local pharmacy or registered program about the product and training. If someone may be overdosing, call 911 right away; naloxone is emergency first aid, not a substitute for medical care.

Sources, Methodology & Editorial Standards

  1. CMS, Medicare Opioid Treatment Program Providers file (September 8, 2026)
  2. Indiana FSSA DMHA, Opioid Treatment Program and agency guidance (accessed October 2026)
  3. Indiana 211, Frequently Asked Questions (accessed October 2026)
  4. Indiana Department of Health, 2026 overdose-intervention standing order (effective January 1–December 31, 2026)
  5. Network for Public Health Law, Indiana overdose prevention law fact sheet (2020)
  6. KFF, Medicaid expansion status (accessed October 2026)
  7. KFF, opioid overdose death rates, CDC NCHS data (through 2024)
  8. USAFacts, Indiana overdose deaths, CDC data (2024)
  9. Indiana DMHA, Find a Local Service Provider (accessed October 2026)
  10. Indiana Medicaid (accessed October 2026)
  11. Indiana DMHA, Apply for Services (accessed October 2026)

This directory was compiled from the CMS Medicare-enrolled OTP provider file, with location counts and county groupings checked against its September 8, 2026 version. Indiana agency materials, Medicaid guidance and published CDC-based overdose statistics support the other sections. Clinic schedules, network status and clinical policies may change after publication.

MATClinicGuide.com is an educational and treatment-navigation resource. It does not own or operate the listed clinics and does not diagnose, prescribe or deliver care. Its helpline reaches MATClinicGuide’s treatment-navigation line, not the individual clinic shown in a listing; calls may be handled by or routed to participating treatment providers or navigation partners. Confirm care, costs and scheduling directly with a clinic. In emergencies, call 911; for mental-health crisis support, call or text 988.

Read our editorial policy, medical disclaimer and advertising and referral disclosure.

MAT Clinics in Nearby States

Looking for treatment options across state lines? Explore these neighboring state guides or browse the full nationwide directory.

📞 Call Now